BioELife Corp.
BioELife Corp. (LITH) Revenue
Annual & quarterly revenue history · segment & region breakdown
LITH · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBioELife Corp. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2018.
Revenue trend
2018 – 2007 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2018-12-31 | $0.00B | +$0.00B | — |
| 2017-12-31 | $0.00B | +$0.00B | — |
| 2016-12-31 | $0.00B | +$0.00B | — |
| 2015-12-31 | $0.00B | +$0.00B | — |
| 2014-12-31 | $0.00B | +$0.00B | — |
| 2013-12-31 | $0.00B | +$0.00B | — |
| 2012-12-31 | $0.00B | +$0.00B | — |
| 2011-12-31 | $0.00B | +$0.00B | — |
| 2010-12-31 | $0.00B | +$0.00B | — |
| 2009-12-31 | $0.00B | +$0.00B | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income BioELife Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
BioELife Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from BioELife Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
LITH revenue · 4 questionsLITH's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2018.
▸ Source: FMP · BioELife Corp. SEC filings · GAAP · BioELife Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026